SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-205456
Filing Date
2019-07-29
Accepted
2019-07-29 16:30:06
Documents
11
Period of Report
2019-07-29

Document Format Files

Seq Description Document Type Size
1 6-K d756141d6k.htm 6-K 17057
2 EX-99.1 d756141dex991.htm EX-99.1 1189374
3 EX-99.2 d756141dex992.htm EX-99.2 12918
4 EX-99.3 d756141dex993.htm EX-99.3 12960
5 EX-99.4 d756141dex994.htm EX-99.4 37405
6 GRAPHIC g756141g0729152608074.jpg GRAPHIC 2125
7 GRAPHIC g756141g0729153904855.jpg GRAPHIC 2535
8 GRAPHIC g756141page028.jpg GRAPHIC 359330
9 GRAPHIC g756141page029.jpg GRAPHIC 437699
10 GRAPHIC g756141page030.jpg GRAPHIC 343840
11 GRAPHIC g756141page031.jpg GRAPHIC 174464
  Complete submission text file 0001193125-19-205456.txt   3089839
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 19981542
SIC: 2834 Pharmaceutical Preparations